- Previous Close
17.59 - Open
18.25 - Bid 17.77 x --
- Ask 17.78 x --
- Day's Range
17.41 - 17.86 - 52 Week Range
11.01 - 29.90 - Volume
1,332,670 - Avg. Volume
3,922,070 - Market Cap (intraday)
1.94B - Beta (5Y Monthly) 1.18
- PE Ratio (TTM)
889.00 - EPS (TTM)
0.02 - Earnings Date --
- Forward Dividend & Yield 0.10 (0.57%)
- Ex-Dividend Date May 27, 2024
- 1y Target Est
--
Zhejiang Tailin BioEngineering Co.,Ltd manufactures microbial test and control equipment, mainly for pharmaceutical and medical sector. The company offers sterility testing equipment, microbiological testing equipment, TOC analyzers, sterile isolation systems, hydrogen peroxide sterilization systems, sterile delivery system, and filters, as well as technical services. Its products are primarily used in bio-pharmaceutical, medical, disease control, food, environmental protection, electronics, and other fields, as well as in bio-security equipment manufacturing industries. The company was formerly known as Hangzhou Tailin Biotechnology Equipment Co., Ltd. and changed its name to Zhejiang Tailin BioEngineering Co.,Ltd in April 2015. Zhejiang Tailin BioEngineering Co.,Ltd was founded in 1993 and is based in Hangzhou, China.
www.tailingood.comRecent News: 300813.SZ
Performance Overview: 300813.SZ
Trailing total returns as of 6/18/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 300813.SZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 300813.SZ
Valuation Measures
Market Cap
1.92B
Enterprise Value
1.70B
Trailing P/E
879.50
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
7.99
Price/Book (mrq)
2.93
Enterprise Value/Revenue
6.27
Enterprise Value/EBITDA
152.01
Financial Highlights
Profitability and Income Statement
Profit Margin
2.94%
Return on Assets (ttm)
-0.41%
Return on Equity (ttm)
0.97%
Revenue (ttm)
270.92M
Net Income Avi to Common (ttm)
7.97M
Diluted EPS (ttm)
0.02
Balance Sheet and Cash Flow
Total Cash (mrq)
381.3M
Total Debt/Equity (mrq)
24.52%
Levered Free Cash Flow (ttm)
-173.22M